Women Experience Faster Cognitive Decline with Age

A new analysis finds higher baseline cognition scores for aging women, but a more rapid drop once cognitive decline begins.

2:18 PM

Author | Haley Otman

drawing of brain in blue ink with lab note badge in yellow bottom right
Michigan Medicine

Women may start middle age with stronger brain function than men, but as they get older, women's cognition declines faster.

That's according to a new analysis from more than 26,000 Black and white men and women who had participated in one of five long-term cohort studies. The researchers found that women had significantly faster declines in overall cognition and executive function, the brain processes used in problem-solving, planning and managing your time. However, memory decline was comparable between men and women.

"We estimate that cognitive function in women declined around five years faster than their ages would suggest," says lead author Deborah Levine, M.D., M.P.H., an associate professor of internal medicine and neurology at Michigan Medicine, and director of its Cognitive Health Services Research Program. "Differences in biological, genetic, social and lifestyle factors between men and women might contribute to faster cognitive decline in women, and more research is needed."

Researchers attribute the higher initial cognitive levels in women to greater cognitive reserve. Women's higher initial scores might delay detecting thinking difficulties, so it's important for loved ones and physicians to closely monitor older women for the first signs of cognitive decline, Levine says.

Paper cited: "Sex Differences in Cognitive Decline Among US Adults," JAMA Network Open. DOI: 10.1001/jamanetworkopen.2021.0169


More Articles About: Lab Notes Gender Alzheimer's Disease Womens Health All Research Topics Health Care Delivery, Policy and Economics Geriatrics Demographics
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories green background with white drawing of doctor at patient beside having conversation
Health Lab
Have a seat, doctor: Study suggests eye level connection makes a difference in hospitals
When doctors sit at hospitalized patients’ bedsides, it can have a more positive impact than if they stand, a review of data suggests – but a new study seeks to find out for sure.
blood pressure cuff on mans arm with white coat doctor taking it
Health Lab
Blood pressure high for years? Beware of stroke risk
A study led by Michigan Medicine narrows in on the cumulative effects of years of high systolic blood pressure — the top number on the blood pressure reading and how hard the heart pumps blood to the arteries — finding that a higher average reading during adulthood is linked with a greater risk for the two most common types of stroke.
bottle cap red
Health Lab
Bipolar disorder and alcohol: It’s not as simple as 'self-medication'
People with bipolar disorder have a high risk of alcohol use issues, which have been seen as “self medication,” but a study shows that changes in drinking predict worse symptoms.
iv chemo bags
Health Lab
Drug-chemo combo increases cancer treatment efficacy
A study finds giving a fatty acid inhibitor alongside chemotherapy could improve the treatment efficacy for patients with brain metastases from triple negative breast cancer
white coats hanging and one swinging off hanger with purple haze over them and sunshine peeking through
Health Lab
Who feels ready for residency?
Helen Morgan, M.D., of Michigan Medicine, authored a study that surveyed obstetric and gynecology residents to determine who feels prepared for the transition from medical school to residency.
close up photo of yellow pills lined up on a bright blue matt
Health Lab
New drug candidate blocks resistance to cancer therapies
A team of researchers at the University of Michigan Health Rogel Cancer Center has designed a molecule that impairs signaling mediated by two key drivers of cancer therapy resistance.